Dariusz Dudek

Randomized Study to Assess the Effectiveness of Slow- and Moderate-Release Polymer-Based Paclitaxel-Eluting Stents for Coronary Artery Lesions

Antonio Colombo, J Drzewiecki, Adrian Banning et al. · Circulation · 2003 · 1K citations · Full text

A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods

Patrick W. Serruys, John A. Ormiston, Yoshinobu Onuma et al. · The Lancet · 2009 · 816 citations

Percutaneous Coronary Intervention, Cardiovascular Translational Research, Cardiovascular Disease +10

A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial

John A. Ormiston, Patrick W. Serruys, Evelyn Regar et al. · The Lancet · 2008 · 714 citations

Percutaneous Coronary Intervention, Prospective Open-label Trial, Cardiovascular Disease +6

Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial

Daniel J.F.M. Thuijs, A. Pieter Kappetein, Patrick W. Serruys et al. · The Lancet · 2019 · 618 citations · Full text

Percutaneous Coronary Intervention, Controlled Syntax Trial, Endovascular Technique +8

A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial

Patrick W. Serruys, Bernard Chevalier, Dariusz Dudek et al. · The Lancet · 2014 · 556 citations · Full text

Percutaneous Coronary Intervention, Absorb Ii, Endovascular Technique +11